These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 29898440

  • 1. Results of Cervical Cancer Screening in the Rural Population of Lucknow West, India, through a Camp Approach.
    Misra JS, Srivastava AN, Gupta HP.
    Acta Cytol; 2018; 62(4):273-278. PubMed ID: 29898440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
    Whop LJ, Baade P, Garvey G, Cunningham J, Brotherton JM, Lokuge K, Valery PC, O'Connell DL, Canfell K, Diaz A, Roder D, Gertig DM, Moore SP, Condon JR.
    PLoS One; 2016; 11(4):e0150473. PubMed ID: 27064273
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS, Gupta HP, Das V.
    Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
    [Abstract] [Full Text] [Related]

  • 14. Age Specific Cytological Abnormalities in Women Screened for Cervical Cancer in the Emirate of Abu Dhabi.
    Al Zaabi M, Al Muqbali S, Al Sayadi T, Al Ameeri S, Coetsee K, Balayah Z, Ortashi O.
    Asian Pac J Cancer Prev; 2015 Dec; 16(15):6375-9. PubMed ID: 26434845
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M, Hoque E, Kader SB.
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.
    Tao X, Austin RM, Zhang H, Zhang L, Xiao J, Zhou X, Wang L, Zhao C.
    Cancer Cytopathol; 2017 Dec; 125(12):947-953. PubMed ID: 28885778
    [Abstract] [Full Text] [Related]

  • 18. Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey.
    Nayir T, Okyay RA, Nazlican E, Yesilyurt H, Akbaba M, Ilhan B, Kemik A.
    Asian Pac J Cancer Prev; 2015 Dec; 16(16):6909-12. PubMed ID: 26514466
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A, Pruski D, Iwaniec K, Kędzia W.
    Ginekol Pol; 2017 Dec; 88(3):141-146. PubMed ID: 28397203
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.